Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases - a podcast by BMJ Group

In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Guarav Gulsin from the University of British Columbia. They cover everything you need to know about this class of drugs for use in heart disease and beyond following the publication of a comprehensive review paper in Heart.

If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2Link to published paper:

https://heart.bmj.com/content/early/2021/05/09/heartjnl-2021-319185

Further episodes of Heart podcast

Further podcasts by BMJ Group

Website of BMJ Group